Rosuvastatin May Reduce the Incidence of Cardiovascular Events in Patients with Acute Coronary Syndromes Receiving Percutaneous Coronary Intervention by Suppressing miR-155/SHIP-1 Signaling Pathway
2014 ◽
Vol 32
(6)
◽
pp. 276-282
◽
2019 ◽
Vol 28
(5)
◽
pp. 727-734
◽
2011 ◽
Vol 58
(5)
◽
pp. 467-473
◽
2021 ◽
Vol 77
(18)
◽
pp. 3416
2016 ◽
Vol 27
(5)
◽
pp. 344-349
◽